4//SEC Filing
Lin Elizabeth Yeu 4
Accession 0001819790-24-000008
CIK 0001819790other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:31 PM ET
Size
5.4 KB
Accession
0001819790-24-000008
Insider Transaction Report
Form 4
Lin Elizabeth Yeu
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2024-01-25+10,000→ 10,000 totalExercise: $26.25Exp: 2034-01-24→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Option granted in connection with certain consulting services being provided by the Reporting Person. The option will vest in full on January 30, 2025, subject to the Reporting Person's continuous service through such date.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001842190
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:31 PM ET
- Size
- 5.4 KB